What the experiment compared
Five healthy men received placebo, berberine or two dihydroberberine regimens in a crossover experiment. Four doses preceded a two-hour blood-sampling period with a test meal. [1]
Some exposure comparisons favored dihydroberberine, but baseline levels differed and several comparisons were only trends. Glucose and insulin showed no significant differences. [1]
Interpretation and limits
An investigator disclosed paid advisory work for NNB Nutrition under an institutional conflict-management plan; funding was not established from the abstract. The tiny sample, brief observation and healthy population cannot establish long-term metabolic superiority or a personal dose conversion. [1]
A hypothetical distinction
Imagine one preparation raises a blood concentration more than another while the clinical marker does not change. Higher exposure remains an absorption finding, not a demonstrated clinical advantage.
| Detail | Interpretation |
|---|---|
| Five participants | Very small pilot |
| Blood exposure | Formulation signal |
| Glucose control | Superiority not demonstrated |
Sources for this article
- Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.